Literature DB >> 11303005

A cardiac prevention and rehabilitation programme for all patients at first presentation with coronary artery disease.

K F Fox1, M Nuttall, D A Wood, M Wright, B Arora, E Dawson, P Devane, K Stock, S J Sutcliffe, K Brown.   

Abstract

OBJECTIVE: To develop and test a cardiac prevention and rehabilitation programme for achieving sustained lifestyle, risk factor, and therapeutic targets in patients presenting for the first time with exertional angina, acute coronary syndromes, or coronary revascularisation.
DESIGN: A descriptive study.
SETTING: A hospital based 12 week outpatient programme.
INTERVENTIONS: A multiprofessional family based programme of lifestyle and risk factor modification. MAIN OUTCOME MEASURES: Non-smoking status, body mass index, blood pressure, plasma cholesterol, use of prophylactic drugs.
RESULTS: 158 patients (82% of 194 possible cases) were recruited over 15 months, with 72% completing the programme. Targets for achieving non-smoking status, blood pressure < 140/90 mm Hg, and total cholesterol < 4.8 mmol/l were achieved in 92%, 73%, and 62%, respectively, and the proportion on aspirin, beta blockers, and lipid lowering treatment was 95%, 58%, and 64% on referral back to general practice for continuing care.
CONCLUSIONS: A comprehensive cardiac prevention and rehabilitation programme can be offered to all patients presenting for the first time with coronary heart disease, including those with exertional angina who are normally managed in primary care. Lifestyle, risk factor, and therapeutic targets can be successfully achieved in most patients with such a hospital based programme.

Entities:  

Mesh:

Year:  2001        PMID: 11303005      PMCID: PMC1729710          DOI: 10.1136/heart.85.5.533

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  13 in total

1.  Why patients do not attend cardiac rehabilitation: role of intentions and illness beliefs.

Authors:  A Cooper; G Lloyd; J Weinman; G Jackson
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

2.  Concordance for coronary risk factors among spouses.

Authors:  D L Sackett; G D Anderson; R Milner; M Feinleib; W B Kannel
Journal:  Circulation       Date:  1975-10       Impact factor: 29.690

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial.

Authors:  G Feder; C Griffiths; S Eldridge; M Spence
Journal:  BMJ       Date:  1999-06-05

5.  Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk.

Authors:  M E Cupples; A McKnight
Journal:  BMJ       Date:  1994-10-15

6.  beta Blockade after myocardial infarction: systematic review and meta regression analysis.

Authors:  N Freemantle; J Cleland; P Young; J Mason; J Harrison
Journal:  BMJ       Date:  1999-06-26

7.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

8.  Dietary change after smoking cessation: a prospective study.

Authors:  R L Thompson; S D Pyke; E A Scott; S G Thompson; D A Wood
Journal:  Br J Nutr       Date:  1995-07       Impact factor: 3.718

Review 9.  An analysis of the effectiveness of interventions intended to help people stop smoking.

Authors:  M Law; J L Tang
Journal:  Arch Intern Med       Date:  1995-10-09

10.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.

Authors:  S Yusuf; D Zucker; P Peduzzi; L D Fisher; T Takaro; J W Kennedy; K Davis; T Killip; E Passamani; R Norris
Journal:  Lancet       Date:  1994-08-27       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.